SAM
PVLA

Sectoral Asset Management’s Palvella Therapeutics PVLA Stock Holding History

Sectoral Asset Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49,115
Closed -$3.08M – 88
2025
Q3 		$3.08M Sell
49,115
-46,500
-49% -$2.07M 1.9% 18
2025
Q2 		$2.16M Buy
+95,615
New +$2.24M 1.42% 16

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Sectoral Asset Management's PVLA Position: Q4 2025 in Review

Sectoral Asset Management sold out of Palvella Therapeutics (PVLA) in Q4 2025, closing a stake of 49,115 shares — an estimated $3.08M sold.

Sectoral Asset Management first reported a position in PVLA in Q2 2025 and held it in 2 quarters. The position peaked at $3.08M in Q3 2025. 140 funds tracked by Wall St. Rank hold PVLA as of Q4 2025.

  • Sectoral Asset Management reported no remaining Palvella Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Sectoral Asset Management sold 49,115 Palvella Therapeutics shares in Q4 2025, an estimated $3.08M.
  • Sectoral Asset Management first reported a position in Palvella Therapeutics in Q2 2025 and held it in 2 quarters.
  • Sectoral Asset Management's Palvella Therapeutics position peaked at $3.08M in Q3 2025.
  • 140 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2025.

Based on Sectoral Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.